These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11142141)

  • 1. [Adjuvant therapy of pancreatic carcinoma].
    Oettle H; Arnold D; Riess H
    Praxis (Bern 1994); 2000 Nov; 89(48):2017-25. PubMed ID: 11142141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant treatment of pancreatic cancer].
    Oettle H
    Zentralbl Chir; 2003 May; 128(5):411-8. PubMed ID: 12813641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.
    Wilkowski R; Thoma M; Bruns C; Wagner A; Heinemann V
    JOP; 2006 Jul; 7(4):349-60. PubMed ID: 16832132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant and additive therapy for cancer of the pancreas].
    Neoptolemos JP; Raraty MG; Ghaneh P; Hickey H; Stocken DD; Dunn JA; Friess H; Büchler MW
    Chirurg; 2003 Mar; 74(3):191-201. PubMed ID: 12647075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
    Regine WF; Winter KA; Abrams R; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Rich TA; Willett CG
    Ann Surg Oncol; 2011 May; 18(5):1319-26. PubMed ID: 21499862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant and adjuvant strategies for pancreatic cancer.
    Ghaneh P; Smith R; Tudor-Smith C; Raraty M; Neoptolemos JP
    Eur J Surg Oncol; 2008 Mar; 34(3):297-305. PubMed ID: 17936564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of pancreatic carcinoma].
    Lutz MP
    Praxis (Bern 1994); 2005 Jun; 94(22):933-5. PubMed ID: 15986638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.
    Landry J; Catalano PJ; Staley C; Harris W; Hoffman J; Talamonti M; Xu N; Cooper H; Benson AB
    J Surg Oncol; 2010 Jun; 101(7):587-92. PubMed ID: 20461765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
    Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
    Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).
    Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA
    BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary and adjuvant radiochemotherapy of pancreatic carcinoma].
    van Tienhoven G
    Praxis (Bern 1994); 2000 Nov; 89(48):2011-6. PubMed ID: 11142140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
    Saif MW
    JOP; 2009 Jul; 10(4):373-7. PubMed ID: 19581737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
    Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Oláh A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Büchler MW;
    JAMA; 2010 Sep; 304(10):1073-81. PubMed ID: 20823433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas].
    André T; Balosso J
    J Chir (Paris); 1999 Dec; 136(6):309-17. PubMed ID: 10675820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future chemoradiation strategies in pancreatic cancer.
    Crane CH; Varadhachary G; Pisters PW; Evans DB; Wolff RA
    Semin Oncol; 2007 Aug; 34(4):335-46. PubMed ID: 17674962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of adjuvant therapy for pancreatic cancer.
    Katz MH; Fleming JB; Lee JE; Pisters PW
    Oncologist; 2010; 15(11):1205-13. PubMed ID: 21045189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.
    Berlin JD; Catalano P; Thomas JP; Kugler JW; Haller DG; Benson AB
    J Clin Oncol; 2002 Aug; 20(15):3270-5. PubMed ID: 12149301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma.
    Ozkok S; Demirci S; Yalman D; Zeytunlu M; Nart D; Yuzer Y; Coker A; Goker E
    Tumori; 2010; 96(4):560-7. PubMed ID: 20968135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.